Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -11.15 | 35.44 |
PEG Ratio (TTM) | -1.35 | -2.74 |
P/S Ratio (TTM) | 4.15 | 6.39 |
P/B Ratio (TTM) | 31.89 | 5.95 |
P/FCF Ratio (TTM) | -18.91 | 45.33 |
Price to 5YR AVG Earnings Ratio | N/A | 62.55 |
Price to 5YR AVG FCF Ratio | N/A | 34.45 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -29.17% | 5.33% |
ROE (TTM) | -205.41% | 26.24% |
Net Profit Margin (TTM) | -36.74% | 0.94% |
ROIC 5YR AVG | N/A | 4.32% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 6.10% | -10.24% | N/A |
Revenue | 6.47% | 7.28% | N/A |
Net Income | 3.47% | -11.43% | N/A |
Cash Flow | -16.62% | -16.70% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.59 | 2.59 |
Quick Ratio (TTM) | 4.77 | 1.96 |
D/E Ratio (TTM) | 6.22 | -0.04 |
Interest Coverage (TTM) | -2.61 | 13.08 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 7.11 |
LTL to 5YR AVG FCF | N/A | 3.62 |
Shares Outstanding Growth 5YR AVG | N/A | 2.25% |